About Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
During the past decade, Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
According to Clinical.Site data, the most researched conditions in "Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Gastric Neoplasms" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd" in a lesser frequency.
Clinical Trials Intervention Types at Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
Most popular intervention types in "Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd" are "Drug" (5 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (2 trials), "Cisplatin" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
The vast majority of trials in "Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd" are
4 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
Currently, there are NaN active trials in "Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".